Literature DB >> 16277170

Multiple endocrine neoplasia type 2A/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma.

S Gullu1, A Gursoy, M F Erdogan, S Dizbaysak, G Erdogan, N Kamel.   

Abstract

We hereby present a rare variant of multiple endocrine neoplasia type 2A (MEN2A) associated with a rare skin disease primary cutaneous lichen amyloidosis and discrete malignant pheochromocytoma in both adrenal glands and pancreatic tail, and interestingly accompanied ganglioneuroma located in retroperitoneum in a 34-yr-old female. The presence of composite tumor of pheochromocytoma and ganglioneuroma arising in the adrenal glands has been described previously in MEN2A and in sporadic cases. The patient displayed classical signs and symptoms of catecholamine excess. Biochemical screening proved pheochromocytoma. Computed tomography revealed multiple mass lesions in both adrenal glands. It also showed a large heterogeneous mass that clearly discriminated from right adrenal gland in retroperitoneal location. After surgical exploration, both adrenal glands and the suspicious mass in pancreatic tail were removed successfully together with subtotal resection of the retroperitoneal tumor. Histopathologic examinations confirmed the presence of pheochromocytoma in both adrenal glands as well as pancreatic lesion. A retroperitoneal ganglioneuroma was also present. Symptomatic and biochemical evidence of pheochromocytoma subsided after the operation. Further evaluation for medullary thyroid carcinoma and primary hyperparathyroidism confirmed MEN2A. Mutation analysis of the ret proto-oncogene revealed a missense point mutation at position 634 in exon 11, which gives rise to the substitution of a cysteine codon with a tyrosine residue.

Entities:  

Mesh:

Year:  2005        PMID: 16277170     DOI: 10.1007/bf03347557

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

Review 1.  Pathology of multiple endocrine neoplasias 2A and 2B: a review.

Authors:  B C Padberg; K Holl; S Schröder
Journal:  Horm Res       Date:  1992

2.  Hereditary localized pruritus in affected members of a kindred with multiple endocrine neoplasia type 2A (Sipple's syndrome).

Authors:  V Nunziata; R Giannattasio; G Di Giovanni; M R D'Armiento; M Mancini
Journal:  Clin Endocrinol (Oxf)       Date:  1989-01       Impact factor: 3.478

3.  Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis.

Authors:  R F Gagel; M L Levy; D T Donovan; B R Alford; T Wheeler; J A Tschen
Journal:  Ann Intern Med       Date:  1989-11-15       Impact factor: 25.391

4.  RET mutation screening in familial cutaneous lichen amyloidosis and in skin amyloidosis associated with multiple endocrine neoplasia.

Authors:  R M Hofstra; R H Sijmons; T Stelwagen; R P Stulp; B G Kousseff; C J Lips; P M Steijlen; P C Van Voorst Vader; C H Buys
Journal:  J Invest Dermatol       Date:  1996-08       Impact factor: 8.551

5.  A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.

Authors:  D Califano; A D'Alessio; G L Colucci-D'Amato; G De Vita; C Monaco; G Santelli; P P Di Fiore; G Vecchio; A Fusco; M Santoro; V de Franciscis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis.

Authors:  M Seri; I Celli; N Betsos; F Claudiani; G Camera; G Romeo
Journal:  Clin Genet       Date:  1997-02       Impact factor: 4.438

7.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors:  H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

8.  A kindred with multiple endocrine neoplasia type 2A associated with pruritic skin lesions.

Authors:  M J Bugalho; E Limbert; L G Sobrinho; A L Clode; J Soares; J F Nunes; M C Pereira; M A Santos
Journal:  Cancer       Date:  1992-12-01       Impact factor: 6.860

9.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

10.  Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis.

Authors:  I Ceccherini; C Romei; V Barone; F Pacini; E Martino; A Loviselli; A Pinchera; G Romeo
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

View more
  8 in total

1.  The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis.

Authors:  Xiao-Ping Qi; Jian-Zhong Peng; Xiao-Wei Yang; Zhi-Lie Cao; Xiu-Hua Yu; Xu-Dong Fang; Da-Hong Zhang; Jian-Qiang Zhao
Journal:  Endocr Connect       Date:  2018-07-26       Impact factor: 3.335

Review 2.  MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.

Authors:  Jessica Oliboni Scapineli; Lucieli Ceolin; Márcia Khaled Puñales; José Miguel Dora; Ana Luiza Maia
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

3.  Metastatic pheochromocytoma in MEN 2A: A rare association.

Authors:  Rimesh Pal; Ashu Rastogi; Santosh Kumar; Anil Bhansali
Journal:  BMJ Case Rep       Date:  2018-03-28

4.  RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.

Authors:  Xiao-Ping Qi; Jian-Qiang Zhao; Zhen-Guang Chen; Jin-Lin Cao; Juan Du; Nai-Fang Liu; Feng Li; Mao Sheng; Er Fu; Jian Guo; Hong Jia; Yi-Ming Zhang; Ju-Ming Ma
Journal:  Oncotarget       Date:  2015-10-20

Review 5.  5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.

Authors:  Shu-Yuan Li; Yi-Qiang Ding; You-Liang Si; Mu-Jin Ye; Chen-Ming Xu; Xiao-Ping Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

Review 6.  Retroperitoneal composite pheochromocytoma-ganglioneuroma : a case report and review of literature.

Authors:  Jinchen Hu; Jitao Wu; Li Cai; Lei Jiang; Zhiqiang Lang; Guimei Qu; Houcai Liu; Weidong Yao; Guohua Yu
Journal:  Diagn Pathol       Date:  2013-04-15       Impact factor: 2.644

7.  The RET C611Y mutation causes MEN 2A and associated cutaneous

Authors:  Xiao-Ping Qi; Jian-Zhong Peng; Xiao-Wei Yang; Zhi-Li Zao; Xiu-Hua Yu; Xu-Dong Fang; Da-Hong Zhang; Jian-Qiang Zhao
Journal:  Endocr Connect       Date:  2018-09-01       Impact factor: 3.335

Review 8.  Composite Paraganglioma of the Celiac Trunk: A Case Report and a Comprehensive Review of the Literature.

Authors:  Georgios Tzikos; Alexandra Menni; Angeliki Cheva; Ioannis Pliakos; Anastasia Tsakona; Stilianos Apostolidis; Ioannis Iakovou; Antonios Michalopoulos; Theodosios Papavramidis
Journal:  Front Surg       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.